ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,565, issued on April 14, was assigned to DEXCEL PHARMA TECHNOLOGIES LTD. (Jerusalem).
"Stable benzimidazole formulation" was invented by Adel Penhasi (Holon, Israel), Avi Avramoff (Haifa, Israel), Maxim Gomberg (Jerusalem) and Valerie Azoulay (Pardes Hana, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "An omeprazole delayed release tablet comprises a core and an enteric coating over the core. The core consists essentially of omeprazole, lactose, sodium starch glycolate, sodium stearate, and sodium stearyl fumarate. The enteric coating over the core consists essentially of hydroxypropyl methyl cellulose (HPMC) acetate succinate, triethyl citr...